IRulya Therapeutics Inc 10-K for FY2023
IRulya Therapeutics Inc. (IRLA)
10-K
2024-04-01
For: 2023-12-31
View Original
Added on
April 05, 2026
About this 10-K
IRulya Therapeutics Inc filed this 10-K on April 1, 2024, covering the fiscal year ended December 31, 2023 (FY2023).
Headline figures
Fiscal year ended December 31, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Net loss
- $31.39M
- compared with a net loss of $51.66M a year earlier
- Diluted EPS
- -$0.84
- compared with -$1.54 a year earlier